KALA BIO, Inc. Share Price & Technical Analysis
KALA · $2.24 (-6.28%)
Healthcare / Biotechnology
$2.24
-6.28%
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-conc…
Price chart
Seasonality
Jun has 4 positive and 1 negative years (last 5 years shown)
4% return in Jun, 11% avg return in past 3 year Jun month.
-183% return in 2026, -58% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | -25% | -55% | -42% | -60% | 4% | – | – | – | – | – | – | -183% |
| 25 | 24% | -24% | -20% | -32% | -3% | 29% | 44% | 71% | -87% | -47% | 21% | -57% | -82% |
| 24 | -1% | 3% | 6% | -15% | 2% | 1% | -8% | -9% | -3% | 24% | -2% | 2% | 1% |
| 23 | -46% | -41% | 50% | 7% | -7% | 2% | 2% | -10% | -33% | -23% | -13% | 20% | -93% |
| 22 | -28% | -25% | 99% | -51% | -50% | -21% | 10% | -8% | -22% | -43% | -17% | 618% | 462% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$46.47M
P/E ratio
—
52W high
$1,030
52W low
$2.10
Volume
57,798
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is KALA BIO, Inc. share price today?
- KALA BIO, Inc. (KALA) last traded around $2.24 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does KALA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for KALA. Download the app for real-time alerts.
- How can I analyze KALA BIO, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.